Investigating how men and women regulate blood flow in the brain
Official title: Human Cerebral Blood Flow Regulation: Sex, Mechanism, and Stress Differences
Run by University of Wisconsin, Madison · NCT04265053 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study looks at how men and women manage blood flow in the brain during stress to see if there are differences and what causes them.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 111 (estimated) |
| Sponsor | University of Wisconsin, Madison Academic / other |
| Locations | 1 site (Madison, Wisconsin) |
| Trial ID | NCT04265053 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy adults aged 18-40 who are non-hypertensive, non-obese, and have normal blood glucose and lipid levels.
✕Probably not a fit
Patients with a history of cerebrovascular disease, obesity, or those taking hormonal birth control may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study explores the differences in cerebral blood flow (CBF) regulation between men and women, particularly under stress conditions like low oxygen or high carbon dioxide. By administering various medications and using advanced MRI techniques, the researchers aim to uncover the physiological mechanisms that contribute to these differences. The study focuses on healthy adults aged 18-40, minimizing confounding factors such as age and comorbidities. The ultimate goal is to enhance understanding of cerebrovascular disease risk and its relationship with sex and hormonal influences.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for cerebrovascular diseases, particularly by understanding sex-specific mechanisms.
How similar studies have gone: While studies have explored sex differences in cerebrovascular health, this specific approach focusing on younger adults and the physiological mechanisms remains novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All participants will be healthy adults between 18-40 years old, matched for age and aerobic fitness * Participants will be non-hypertensive (\<125/80mm Hg) * Participants will be non-obese (BMI 19-25 kg/m2) * Participants will have normal blood glucose (\<100 g/dl) * Participants will have normal lipids (LDL cholesterol \<130 mg/dl, triglycerides \<150 mg/dl) * Women must have a natural regular menstrual cycle Exclusion Criteria: * Participants with a history of: * peripheral vascular disease * hepatic disease * renal disease * hematologic disease * stroke * obesity * prediabetes * diabetes * sleep apnea * Participants with current BP\>130/85 mmHg * Regular smokers * Taking cardiovascular medications * Women who take hormonal birth control * Women who are pregnant or have polycystic ovarian syndrome \[Hormonal birth control will not be allowed in women\] * Contradictions to MRI * Lactose intolerance
Where it's running
-
University of Wisconsin, Madison
Madison, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: William Schrage, PhD — University of Wisconsin, Madison
- Study coordinator: Shawn E Bolin, MS
- Email: sbolin@wisc.edu
- Phone: 608-263-6308
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulse treatment for acute ischemic stroke
This study is testing a new treatment called the Pulse NanoMED System for people who have had an acute ischemic stroke to see if it can help improve blood flow to the brain after they receive standard care.
-
Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease
This study will see if using CT angiography to plan calcium treatment before stenting helps people with flow-limiting, calcified coronary artery disease have better stent results and faster procedures compared with the usual ultrasound-guided PCI while keeping similar safety.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
-
Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients
This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.
-
Using two stent retrievers at once versus one for treating acute ischemic stroke
We will test whether using two stent retrievers at the same time helps people with acute ischemic stroke get their blocked artery opened faster and recover better during mechanical thrombectomy.
-
Long-term follow-up of Intergard vascular grafts and patches
This registry will see how Intergard grafts and patches perform and stay safe over time in adults who had bypass, repair, or replacement of the aorta, carotid, or peripheral arteries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.